By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clearside Biomedical 

1220 Old Alpharetta Road
Suite 300
Alpharetta   Georgia  30005  U.S.A.
Phone: 678-270-3631 Fax:



Company News
Clearside Biomedical (CLSD) To Present At The 2016 Ladenburg Thalmann Healthcare Conference 9/21/2016 8:56:14 AM
Clearside Biomedical (CLSD) To Present At The 2016 Wedbush PacGrow Healthcare Conference 8/10/2016 10:53:20 AM
Clearside Biomedical (CLSD) Announces Pricing Of Initial Public Offering 6/2/2016 8:24:12 AM
Clearside Biomedical To Present Data On Suprachoroidal Drug Administration At 2016 Association for Research in Vision & Ophthalmology Meeting 4/28/2016 11:07:56 AM
Clearside Biomedical Announces Positive Preliminary Phase 2 Results In Patients With Macular Edema Associated With Retinal Vein Occlusion 4/26/2016 12:25:22 PM
Clearside Biomedical Announces Appointment Of Richard J. Croarkin To The Board Of Directors 2/29/2016 11:19:42 AM
Clearside Biomedical Announces Positive Topline Data From Phase 2 Clinical Trial For The Treatment Of Macular Edema Associated With Non-Infectious Uveitis 1/5/2016 11:27:18 AM
Clearside Biomedical Completes Enrollment In Phase 2 Clinical Trial Of CLS-TA For The Treatment Of Retinal Vein Occlusion Using Suprachoroidal Space (SCS) Drug Administration 12/14/2015 1:02:52 PM
Clearside Biomedical Enrolls First Patient In Phase 3 Clinical Trial Of CLS-TA Using Suprachoroidal Drug Administration 12/7/2015 1:06:25 PM
Clearside Biomedical Nabs $20 Million Series C Financing 12/3/2015 5:59:16 AM